Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Suzanne K. Vosburg, Thomas A. Eaton, Marta Sokolowska, Eric D. Osgood, Judy B. Ashworth, Jeremiah J. Trudeau, Michelle Muffett-Lipinski & Nathaniel P. Katz. (2016) Prescription Opioid Abuse, Prescription Opioid Addiction, and Heroin Abuse Among Adolescents in a Recovery High School: A Pilot Study. Journal of Child & Adolescent Substance Abuse 25:2, pages 105-112.
Read now
Read now
Beth Shoshana Russell, Jeremiah J. Trudeau & Alicia J. Leland. (2015) Social Influence on Adolescent Polysubstance Use: The Escalation to Opioid Use. Substance Use & Misuse 50:10, pages 1325-1331.
Read now
Read now
Joseph V Pergolizzi$suffix/text()$suffix/text(), Gianpietro Zampogna, Robert Taylor$suffix/text()$suffix/text() & Robert B Raffa. (2015) Long-term efficacy, safety and tolerability of Remoxy for the management of chronic pain. Expert Review of Neurotherapeutics 15:3, pages 231-238.
Read now
Read now
Johannes H Bartholomaeus, Elisabeth Arkenau-Marić & Eric Galia. (2012) Opioid extended-release tablets with improved tamper-resistant properties. Expert Opinion on Drug Delivery 9:8, pages 879-891.
Read now
Read now
Articles from other publishers (13)
Lindsey M. Nichols, Jonathan A. Pedroza, Christopher M. Fleming, Kaitlin M. O’Brien & Emily E. Tanner-Smith. (2021) Social-Ecological Predictors of Opioid Use Among Adolescents With Histories of Substance Use Disorders. Frontiers in Psychology 12.
Crossref
Crossref
Cherkaouia Kibaly, Jacob A. Alderete, Steven H. Liu, Hazem S. Nasef, Ping-Yee Law, Christopher J. Evans & Catherine M. Cahill. (2020) Oxycodone in the Opioid Epidemic: High ‘Liking’, ‘Wanting’, and Abuse Liability. Cellular and Molecular Neurobiology 41:5, pages 899-926.
Crossref
Crossref
Cecilia P. Chung, Stephen Todd Callahan, William O. Cooper, William D. Dupont, Katherine T. Murray, Andrew D. Franklin, Kathi Hall, Judith A. Dudley, Charles Michael Stein & Wayne A. Ray. (2019) Individual short‐acting opioids and the risk of opioid‐related adverse events in adolescents. Pharmacoepidemiology and Drug Safety 28:11, pages 1448-1456.
Crossref
Crossref
Daniel Remillard, Alan David Kaye & Heath McAnally. (2019) Oxycodone’s Unparalleled Addictive Potential: Is it Time for a Moratorium?. Current Pain and Headache Reports 23:2.
Crossref
Crossref
Tessa Cheng, Will Small, Huiru Dong, Ekaterina Nosova, Kanna Hayashi & Kora DeBeck. (2018) An age-based analysis of nonmedical prescription opioid use among people who use illegal drugs in Vancouver, Canada. Substance Abuse Treatment, Prevention, and Policy 13:1.
Crossref
Crossref
Meenu Minhas & Francesco Leri. (2017) A Multifaceted Analysis of Oxycodone Addiction. International Journal of Mental Health and Addiction 16:4, pages 1016-1032.
Crossref
Crossref
Emily E. Tanner-Smith, Andrew J. Finch, Emily A. Hennessy & D. Paul Moberg. (2018) Who attends recovery high schools after substance use treatment? A descriptive analysis of school aged youth. Journal of Substance Abuse Treatment 89, pages 20-27.
Crossref
Crossref
Emily A. Hennessy, Emily E. Tanner‐Smith, Andrew J. Finch, Nila Sathe & Shannon Kugley. (2018) Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review. Campbell Systematic Reviews 14:1, pages 1-86.
Crossref
Crossref
Manuela Graziani & Robert Nisticò. (2016) Gender difference in prescription opioid abuse: A focus on oxycodone and hydrocodone. Pharmacological Research 108, pages 31-38.
Crossref
Crossref
Maryann Mazer-Amirshahi, Peter M. Mullins, Irit R. Rasooly, John van den Anker & Jesse M. Pines. (2014) Trends in Prescription Opioid Use in Pediatric Emergency Department Patients. Pediatric Emergency Care 30:4, pages 230-235.
Crossref
Crossref
Stephen C. Harris, Peter J. Perrino, Ira Smith, Megan J. Shram, Salvatore V. Colucci, Cynthia Bartlett & Edward M. Sellers. (2013) Abuse potential, pharmacokinetics, pharmacodynamics, and safety of intranasally administered crushed oxycodone HCl abuse‐deterrent controlled‐release tablets in recreational opioid users. The Journal of Clinical Pharmacology 54:4, pages 468-477.
Crossref
Crossref
Fermin BarruetoJr.Jr., Rajender Gattu & Maryann Mazer-Amirshahi. (2013) Updates in the General Approach to the Pediatric Poisoned Patient. Pediatric Clinics of North America 60:5, pages 1203-1220.
Crossref
Crossref
Peter J. Perrino, Salvatore V. Colucci, Glen Apseloff & Stephen C. Harris. (2013) Pharmacokinetics, Tolerability, and Safety of Intranasal Administration of Reformulated OxyContin® Tablets Compared with Original OxyContin® Tablets in Healthy Adults. Clinical Drug Investigation 33:6, pages 441-449.
Crossref
Crossref